What is the future of Covid-19 vaccines?

The latest stories trending on MedCity News.

Editor's Pick

Top Story The Public Health Emergency Expiring, So What Is the Future of Covid-19 Vaccines? The FDA will decide this summer which strains the next Covid-19 vaccines should address. But companies are also taking a longer view, developing shots for the future that offer different features than the current ones and potentially broader protection against a wider range of pathogens. Sponsored Content How Can Healthcare Prevent Data Overload? Presented by Intelligent Medical Objects and MedCity News This new white paper from Intelligent Medical Objects highlights how the aviation, military, law enforcement industries and other sectors confronted data challenges to improve data collection and what the healthcare industry can learn from these examples. Click here to learn more! Meet These Investor Judges at INVEST Startups are at the heart of the MedCity INVEST conference from Pitch Perfect to Ask the Investor. Check out the investors who will be judging the startups at INVEST May 22-24 in Chicago and register today! Hurry and Save $200 until May 5 - Register Now.

Featured News

How Atrium Health Made Payment a Part of Its Digital Front Door A health system's failure to offer patients with digital payment options could lead to slower collection times, create a disjointed patient financial experience, and result in decreased patient satisfaction and loyalty. At HIMSS23, Atrium Health's vice president of revenue cycle management shared how his system integrated payment into its digital front door and gave pointers to hospitals looking to do the same. Aetna Better Health of Maryland Launches Maternal Health Pilot Program With Mae Mae's services will be a covered benefit for Aetna Better Health Medicaid members through a new pilot program. These services include access to a culturally-competent doula and an engagement platform that provides weekly check-ins and tools to support maternal health. Cardiac Complication Leads FDA to Place Foghorn Cancer Drug Under Partial Hold A clinical trial for a Foghorn Therapeutics cancer drug is under a partial FDA hold after a patient in the early-stage study developed a cardiovascular complication. It's the biotech's second partial hold in the past year. VBC Won't Save Safety Net Hospitals, Experts Say A shift from fee-for-service payment models to value-based models is not an effective way to address the severe financial pressures that safety net hospitals are facing, experts argued at the HIMSS conference in Chicago. One called for a paradigmatic shift "away from cost savings and toward understanding where investments are needed." The challenges of temperature controlled logistics and how to overcome them With more freight moving around the world than ever, combined with increased external circumstances causing supply chain disruptions, there's never been such pressure on the success of temperature controlled logistics as there is now. MedCity News sat down with John Coleman, Business Unit Director at YSDS Life Science, to talk about the challenges of delivering temperature-sensitive goods and how to overcome them. Bringing eCommerce Best Practices to Healthcare to Attract and Retain Patients DexCare is sponsoring a webinar May 19 highlighting how it's taking lessons learned from online retailers to boost traffic and applies them to their healthcare customers. To learn more, register today. Hint Health Partners With Eden Health To Expand Direct Primary Care Network Eden Health will join Hint Health's Hint Connect platform, which is a network of independent direct primary care clinics. Through the partnership, employees of Hint Connect's employer customers will be able to choose whether they want to receive care from a local DPC provider in their area (either in-person or virtually) or a virtual provider through Eden Health. Eli Lilly Unloads Emergency Nasal Spray Diabetes Drug for $500M Up Front Eli Lilly is selling to Amphastar Pharmaceuticals global rights to Baqsimi, an emergency treatment for severe hypoglycemia in diabetes patients. The deal come as Lilly turns its focus to novel medicines for diabetes and other indications.

Resources

MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Dr. Rob Fields, Beth Israel Lahey Health's New Chief Clinical Officer For this episode's guest interview, we hear from Dr. Rob Fields, who recently became the chief clinical officer at Beth Israel Lahey Health. He comes to the role after serving as Mount Sinai's chief population health officer.  Listen Now

MedCity News • 611 Broadway • New York, NY unsubscribe